Logo image of ONCO

ONCONETIX INC (ONCO) Stock Overview

USA - NASDAQ:ONCO - US68237Q2030 - Common Stock

3.1 USD
+0.05 (+1.64%)
Last: 9/15/2025, 5:33:46 PM

ONCO Key Statistics, Chart & Performance

Key Statistics
52 Week High552.5
52 Week Low2.61
Market Cap4.80M
Shares1.55M
Float1.24M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-593.67
PEN/A
Fwd PEN/A
Earnings (Next)12-08 2025-12-08
IPO02-18 2022-02-18
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology


ONCO short term performance overview.The bars show the price performance of ONCO in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -20 -40 -60

ONCO long term performance overview.The bars show the price performance of ONCO in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30 -40 -50

The current stock price of ONCO is 3.1 USD. In the past month the price increased by 5.8%. In the past year, price decreased by -55.74%.

ONCONETIX INC / ONCO Daily stock chart

ONCO Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 20.55 384.42B
AMGN AMGEN INC 12.58 147.73B
GILD GILEAD SCIENCES INC 14.54 139.64B
VRTX VERTEX PHARMACEUTICALS INC 23.21 100.82B
REGN REGENERON PHARMACEUTICALS 12.55 60.69B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 60.45B
ARGX ARGENX SE - ADR 81.64 46.32B
ONC BEONE MEDICINES LTD-ADR 5.81 39.50B
INSM INSMED INC N/A 30.26B
NTRA NATERA INC N/A 23.63B
BNTX BIONTECH SE-ADR N/A 23.53B
BIIB BIOGEN INC 8.95 21.01B

About ONCO

Company Profile

ONCO logo image Onconetix, Inc. is a commercial stage biotechnology company, which engages in the research, development and commercialization of proprietary therapeutics, diagnostics and services for clinicians and patients for oncology. The company is headquartered in Cincinnati, Ohio and currently employs 5 full-time employees. The company went IPO on 2022-02-18. The firm owns Proclarix, an in vitro diagnostic test for prostate cancer approved for sale in the European Union under the In Vitro Diagnostic Regulation. Proclarix is an easy-to-use next generation protein-based blood test that can be done with the same sample as a patient’s regular Prostate-Specific Antigen (PSA) test.

Company Info

ONCONETIX INC

201 E. Fifth Street, Suite 1900

Cincinnati OHIO US

Employees: 5

ONCO Company Website

ONCO Investor Relations

Phone: 15136204101

ONCONETIX INC / ONCO FAQ

What is the stock price of ONCONETIX INC today?

The current stock price of ONCO is 3.1 USD. The price increased by 1.64% in the last trading session.


What is the ticker symbol for ONCONETIX INC stock?

The exchange symbol of ONCONETIX INC is ONCO and it is listed on the Nasdaq exchange.


On which exchange is ONCO stock listed?

ONCO stock is listed on the Nasdaq exchange.


What is ONCONETIX INC worth?

ONCONETIX INC (ONCO) has a market capitalization of 4.80M USD. This makes ONCO a Nano Cap stock.


How many employees does ONCONETIX INC have?

ONCONETIX INC (ONCO) currently has 5 employees.


What are the support and resistance levels for ONCONETIX INC (ONCO) stock?

ONCONETIX INC (ONCO) has a support level at 2.67 and a resistance level at 3.1. Check the full technical report for a detailed analysis of ONCO support and resistance levels.


Should I buy ONCONETIX INC (ONCO) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does ONCONETIX INC (ONCO) stock pay dividends?

ONCO does not pay a dividend.


When does ONCONETIX INC (ONCO) report earnings?

ONCONETIX INC (ONCO) will report earnings on 2025-12-08.


What is the Price/Earnings (PE) ratio of ONCONETIX INC (ONCO)?

ONCONETIX INC (ONCO) does not have a PE ratio as the earnings reported over the last twelve months were negative (-593.67).


What is the Short Interest ratio of ONCONETIX INC (ONCO) stock?

The outstanding short interest for ONCONETIX INC (ONCO) is 5.11% of its float. Check the ownership tab for more information on the ONCO short interest.


ONCO Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to ONCO. When comparing the yearly performance of all stocks, ONCO is a bad performer in the overall market: 95.88% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

ONCO Financial Highlights

Over the last trailing twelve months ONCO reported a non-GAAP Earnings per Share(EPS) of -593.67. The EPS increased by 93.35% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -240.02%
ROE -722.3%
Debt/Equity 1.37
Chartmill High Growth Momentum
EPS Q2Q%99.78%
Sales Q2Q%-84.89%
EPS 1Y (TTM)93.35%
Revenue 1Y (TTM)-9.35%

ONCO Forecast & Estimates


Analysts
Analysts43.33
Price TargetN/A
EPS Next Y-16.47%
Revenue Next YearN/A

ONCO Ownership

Ownership
Inst Owners0.82%
Ins Owners1.41%
Short Float %5.11%
Short Ratio0.08